spacer
home > news
INDUSTRY NEWS AND PRESS RELEASES

3P Biopharmaceuticals renews its “Credit Impôt Recherche” (CIR) by the French Ministry of Higher Education and Research

CIR certificate is extended for a four-year period between 2020-2024 [

[Noáin, April 22, 2020] 3P Biopharmaceuticals, a European leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics, has successfully extended its French CIR certificate for another four-year period: 2020-2024. More>>

 
web https://www.3pbio.com/
 

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

Patients monitor cardiac safety at home with easy-to-use, FDA-cleared KardiaMobile 6L personal ECG

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a first-of-its-kind partnership with AliveCor, the leader in AI-based, personal ECG technology. The partnership enables ERT to capture digital cardiac safety data with KardiaMobile 6L, the only FDA-cleared personal ECG for patient-administered 6-lead data collection. More>>

 
phone +1 800 961 5004
email eresearch@ert.com
web www.ert.com
email 1818 Market Street, Suite 1000, Philadelphia, PA 19103
 

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020. First deliveries to UN agencies such as UNICEF and PAHO are expected by

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines. More>>

 
phone +45 25528170
email info@AJVaccines.com
web https://ajvaccines.com/
 

Sphere Fluidics receives Queen’s Award for Enterprise

Single cell analysis for therapeutic discovery recognized with prestigious business award for innovation

Cambridge, UK, 21 April 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, has be honored with a Queen’s Award for Enterprise for Innovation. The award recognizes the Company’s excellence in patenting, developing and globally commercializing single cell analysis systems for biotherapeutic discovery. More>>

 
phone +44 1223 804200
email info@spherefluidics.com
web www.spherefluidics.com
email The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
 

Specialized expertise that gives you an inside edge

Tap into the knowledge of specialists with decades of experience identifying and solving difficult challenges. From technical obstacles such as siliconization and lyophilization to strategic issues such as life cycle planning, Vetter’s integrated team approach brings together the right experts for your compound’s precise requirements. More>>

 
phone +49 751 3700 0
email info@vetter-pharma.com
web www.vetter-pharma.com
email Eywiesenstraße 5, 88212 Ravensburg, Germany
 

Symphony Health to provide free access to new Metys COVID-19 Module for U.S. based life sciences industry during pandemic

Metys COVID-19 Module delivers pharmaceutical market analytics and intelligence quickly through a single access point

RALEIGH, N.C., April 08, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today that Symphony Health, a PRA Health Sciences company, will make a 30-day license of its newly released MetysTM COVID-19 Module available to the U.S. life science industry at no charge. More>>

 
phone +44 (118) 918-1000
email prahealthsciences@prahs.com
web www.prahs.com
email Green Park, 500 South Oak Way, Reading, RG2 6AD UK
 

Avacta and Cytiva collaborating on COVID-19 rapid test

Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening

Cambridge and Wetherby, UK, 08 April 2020: Avacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection. More>>

 
phone +44 (0) 844 414 0452
web www.avacta.com
 

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

April 1, 2020 – ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced multiple options that enable trained healthcare professionals to advance respiratory clinical trials by collecting high-quality spirometry data during patient home visits. ERT’s At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patient access to investigative sites is limited due to COVID19 stay-at-home mandates. More>>

 
phone +1 800 961 5004
email eresearch@ert.com
web www.ert.com
email 1818 Market Street, Suite 1000, Philadelphia, PA 19103
 

Labguru integrates free video conferencing & documenting tool to support remote lab collaboration during COVID-19

2 April 2020, Cambridge MA – Electronic laboratory notebook (ELN) pioneer, BioData, today announces its support for the global science community with the introduction of a new video conferencing service in its leading Labguru ELN platform, free of charge for all customers. More>>

 
phone +1-617-714-9952
web www.labguru.com
email 625 Massachusetts Ave, Cambridge, MA 02139, USA
 

Sense Accelerates Instrument-Free Molecular Diagnostic Test for COVID-19

Pioneering new class of diagnostic product will transform fight against pandemic Scale-up with Phillips-Medisize underway to ensure timely delivery and distribution

April 1, 2020 – Sense Biodetection Limited (Sense) has today announced an accelerated programme to launch the world’s first instrument-free, point-of-care molecular diagnostic test for SARS-CoV-2, the coronavirus responsible for the COVID-19 pandemic. More>>

 
phone +31 252 576 888
email eu_sales@phillipsmedisize.com
web www.phillipsmedisize.com
email Edisonstraat 1 Hillegom 2181 AB
 
spacer
News and Press Releases

Merck Introduces Parteck® COAT Excipient, a Fast-Dissolving Material for Immediate Release Coating

• Designed to simplify the formulation and coating process for tablets • Optimized particle size leads to fast dissolving and increases coating process efficiency Merck has launched its Parteck® COAT excipient, a new functional material designed for immediate release film coating applications. Parteck® COAT is a particle engineered polyvinyl alcohol (PVA) with a unique particle structure that enables rapid dissolution even at low temperatures leading to an increased process efficiency.
More info >>


White Papers

Nanoparticle Tracking Analysis. A Review of Applications and Usage in the Analysis of Exosomes and Microvesicles

NanoSight

The study of exosomes and other cell-derived microvesicles is an area of rapidly growing importance and the subject of intense interest and research. The previous lack of suitable methods for their detection, analysis, enumeration and phenotyping is proving to be a significant limitation in these studies. This mini-review shows the degree to which the technique of Nanoparticle Tracking Analysis (NTA) is helping to address these problems.
More info >>

Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement